tiprankstipranks
Illumina says Icahn’s nominees ‘lack relevant skills and experience’
The Fly

Illumina says Icahn’s nominees ‘lack relevant skills and experience’

Illumina responded to Carl Icahn by stating, in part, "A company of Illumina’s value creation potential requires a Board invested and experienced in creating clinical markets, driving operational excellence, harnessing the power of science, and realizing a vision for future growth. Illumina’s Board brings extensive and diverse business, financial, operating, regulatory and scientific backgrounds in the life sciences and technology sectors, and have presided over the growth of biotech companies, run public life sciences and technology companies, and brought world-class products to market. The Board is led by an independent chair and all nine members are independent, except for the CEO. The Board and management team have a proven track record of successfully managing the core business, and a plan to resolve the acquisition of GRAIL expeditiously and in a manner that is in the best interests of Illumina’s shareholders. Illumina’s Board of Directors is committed to maximizing value for all shareholders and has always welcomed constructive engagement with the investment community. Illumina’s Nominating/Corporate Governance Committee interviewed each of Icahn’s nominees and found that they lacked relevant skills and experience. At this time, shareholders are not required to take any action with respect to Icahn. Illumina will file preliminary materials with respect to the 2023 Annual Meeting of Shareholders in the coming weeks."

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on ILMN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles